Geron Corp (GERN)
3.695
-0.04
(-0.94%)
USD |
NASDAQ |
Apr 19, 16:00
3.70
0.00 (0.00%)
After-Hours: 20:00
Geron Cash from Investing (Quarterly): 47.57M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.57M |
| September 30, 2023 | -4.714M |
| June 30, 2023 | -44.44M |
| March 31, 2023 | -178.73M |
| December 31, 2022 | 18.99M |
| September 30, 2022 | 9.842M |
| June 30, 2022 | 2.81M |
| March 31, 2022 | 30.43M |
| December 31, 2021 | 8.365M |
| September 30, 2021 | -5.406M |
| June 30, 2021 | 30.90M |
| March 31, 2021 | 38.08M |
| December 31, 2020 | -21.84M |
| September 30, 2020 | 13.56M |
| June 30, 2020 | -129.21M |
| March 31, 2020 | 32.16M |
| December 31, 2019 | -7.013M |
| September 30, 2019 | 6.037M |
| June 30, 2019 | 19.41M |
| March 31, 2019 | 8.964M |
| December 31, 2018 | 0.848M |
| September 30, 2018 | -9.349M |
| June 30, 2018 | -66.61M |
| March 31, 2018 | -2.608M |
| December 31, 2017 | 9.744M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.722M |
| June 30, 2017 | -3.854M |
| March 31, 2017 | 9.358M |
| December 31, 2016 | 7.518M |
| September 30, 2016 | 4.147M |
| June 30, 2016 | 0.792M |
| March 31, 2016 | -3.694M |
| December 31, 2015 | 8.866M |
| September 30, 2015 | 5.72M |
| June 30, 2015 | 11.87M |
| March 31, 2015 | -26.39M |
| December 31, 2014 | 6.189M |
| September 30, 2014 | 2.447M |
| June 30, 2014 | 3.241M |
| March 31, 2014 | -89.78M |
| December 31, 2013 | 4.14M |
| September 30, 2013 | 6.049M |
| June 30, 2013 | 1.207M |
| March 31, 2013 | 9.658M |
| December 31, 2012 | 16.40M |
| September 30, 2012 | 16.27M |
| June 30, 2012 | 8.776M |
| March 31, 2012 | 19.51M |
| December 31, 2011 | 7.686M |
| September 30, 2011 | 11.94M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-178.73M
Minimum
Mar 2023
47.57M
Maximum
Dec 2023
-7.010M
Average
8.365M
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -362.12M |
| SELLAS Life Sciences Group Inc | 0.00 |
| Johnson & Johnson | -1.202B |
| Immuneering Corp | 3.133M |
| Moderna Inc | -538.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.94M |
| Cash from Financing (Quarterly) | 33.28M |
| Free Cash Flow | -168.57M |
| Free Cash Flow Per Share (Quarterly) | -0.0689 |
| Free Cash Flow to Equity (Quarterly) | -71.05M |
| Free Cash Flow Yield | -8.05% |